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Abstract
Significant selection pressure has been exerted on the genomes of human populations
exposed to Plasmodium falciparum infection, resulting in the acquisition of mechanisms of
resistance against severe malarial disease. Many host genetic factors, including sickle cell
trait, have been associated with reduced risk of developing severe malaria, but do not
account for all of the observed phenotypic variation. Identification of novel inherited risk
factors relies upon high-resolution genome-wide association studies (GWAS). We present
findings of a GWAS of severe malaria performed in a Tanzanian population (n = 914, 15.2
million SNPs). Beyond the expected association with the sickle cell HbS variant, we identify
protective associations within two interleukin receptors (IL-23R and IL-12RBR2) and the
kelch-like protein KLHL3 (all P<10−6), as well as near significant effects for Major Histocom-
patibility Complex (MHC) haplotypes. Complementary analyses, based on detecting
extended haplotype homozygosity, identified SYNJ2BP, GCLC and MHC as potential loci
under recent positive selection. Through whole genome sequencing of an independent Tan-
zanian cohort (parent-child trios n = 247), we confirm the allele frequencies of common poly-
morphisms underlying associations and selection, as well as the presence of multiple
structural variants that could be in linkage with these SNPs. Imputation of structural variants
in a region encompassing the glycophorin genes on chromosome 4, led to the characterisa-
tion of more than 50 rare variants, and individually no strong evidence of associations with
severe malaria in our primary dataset (P>0.3). Our approach demonstrates the potential of
a joint genotyping-sequencing strategy to identify as-yet unknown susceptibility loci in an
African population with well-characterised malaria phenotypes. The regions encompassing
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these loci are potential targets for the design of much needed interventions for preventing or
treating malarial disease.
Author summary
Malaria, caused by Plasmodium falciparum parasites, is a major cause of mortality and
morbidity in endemic countries of sub-Saharan Africa, including Tanzania. Some gene
mutations in the human genome, including sickle cell trait, have been associated with
reduced risk of developing severe malaria, and have increased in frequency through natu-
ral selection over generations. However, new genetic mutations remain to be discovered,
and recent advances in human genome research technologies such as genome-wide asso-
ciation studies (GWAS) and fine-scale molecular genotyping tools, are facilitating their
identification. Here, we present findings of a GWAS of severe malaria performed in a well
characterised Tanzanian population (n = 914). We confirm the expected association with
the sickle cell trait, but also identify new gene targets in immunological pathways, some
under natural selection. Our approach demonstrates the potential of using GWAS to iden-
tify as-yet unknown susceptibility genes in endemic populations with well-characterised
malaria phenotypes. The genetic mutations are likely to form potential targets for the
design of much needed interventions for preventing or treating malarial disease.
Introduction
Sub-Saharan Africa bears a disproportionately high share of the global Plasmodium falciparum
malaria burden, with 90% of the estimated 212 million annual cases and 92% of 429,000 annual
deaths, mostly in children under five years of age [1]. Whilst the majority of cases of Plasmo-
dium falciparum infection are asymptomatic or cause only mild to moderate clinical symp-
toms, a subset of affected individuals present with severe manifestations such as severe
malarial anaemia and cerebral malaria. Risk factors for severe malaria and its various clinical
subtypes are poorly understood, although host and parasite genotype, age and immune status
have all been established as playing a significant role in individual host susceptibility [2]. Plas-
modium falciparum has also exerted significant selection pressure upon the human genome, as
evidenced by the geographical concurrence of malaria parasite prevalence with sickle cell trait
(HbAS) and other haemoglobinopathies, such as the thalassemias and glucose-6-phosphate
dehydrogenase (G6PD) deficiency.
Recent studies, set in a region of high malaria transmission in north-eastern Tanzania, esti-
mated that host genetic factors account for approximately 22% of the total variation in severe
malaria risk [3], consistent with previous findings in a Kenyan family-based study [2]. Less
than half of this variation can be explained by erythrocyte-associated polymorphisms [4],
including HbS (sickle cell trait), alpha-thalassaemia, ABO blood group [5] and G6PD defi-
ciency [4]. Novel polymorphisms in or around USP38, FREM3 [3], glycophorins gypA/B/E [6,
7], DDC [8], MARVELD3 and ATP2B4 [9] account for additional variation but, in sum, are
less protective than heterozygous carriage of HbS [3]. Moreover, the effects of some of these
loci are subtype-, location-, or population-specific [3, 6, 7, 9], reinforcing the need for targeted
genome-wide association studies (GWAS) in different African populations. Utilising such an
approach with robust malaria phenotypes in parallel with whole genome sequencing of study
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populations is crucial to unravelling host genetic factors that could lead to a greater under-
standing of protective immunity and development of new tools for disease prevention.
To identify novel loci associated with severe malaria in north-eastern Tanzania, we applied
genome-wide association and haplotype-based selection methods to a case-control dataset
with extensive phenotypic data for 914 participants and 15.2 million SNPs. In addition to the
expected HbS (sickle cell) association, our analyses reveal multiple novel loci under association
or selection. Association analysis highlighted significant SNPs clusters within IL-23R, IL-
12RB2, LINC00944, and KLHL3 whilst lone SNP associations were also present within
TREML4 and ZNF536. Further, we reveal loci under recent positive selection including GCLC
and loci within the Major Histocompatibility Complex (MHC). These analyses were supported
by whole genome sequencing of an independent dataset consisting of 247 Tanzanian individu-
als within parent-child trios, which was used to confirm the allele frequencies of putative asso-
ciations and determine if there are any linked common structural variants in chromosome
regions encoding important polymorphisms.
Results
Phenotypic and genotypic data
All severe malaria cases (n = 449) and controls (n = 465) came from the Tanga region of North-
Eastern Tanzania. Severe malaria cases presented with varying combinations of hyperlactataemia
(57.0%), severe malarial anaemia (49.2%), respiratory distress (27.6%) and cerebral malaria
(26.7%) (Table 1). Compared to controls, malaria cases were younger (t test P<2.2x10
-16) and mar-
ginally more likely to be male (Chi squared P = 0.012) (Table 1). DNA from all samples (n = 914)
Table 1. Study participants.
Controls
(n = 465)
Cases
(n = 449)
Difference
P-value
Age (median, range) 2.8 0.9–10.9 1.7 0.2–10.0 <2.2x10
-16
Female 252 54.2% 205 45.7% 0.012
Ethnicity 0.52
Mzigua 151 32.5% 146 32.5%
Wasambaa 142 30.5% 135 30.1%
Wabondei 83 17.8% 86 19.2%
Mmbena 26 5.6% 23 5.1%
Mngoni 17 3.7% 18 4.0%
Pare 11 2.4% 8 1.8%
Mmakonde 11 2.4% 8 1.8%
Mgogo 7 1.5% 8 1.8%
Chagga 9 1.9% 7 1.6%
Other 8 1.7% 10 2.2%
Mixed Ethnicity 150 32.3% 172 38.2% 0.065
Hyperlactatemia/acidosis - - 256 57.0% -
Severe Malarial Anaemia - - 221 49.2% -
Respiratory Distress - - 124 27.6% -
Cerebral Malaria - - 120 26.7% -
 months
 based on paternal ethnicity
 if parental ethnicities were different
https://doi.org/10.1371/journal.pgen.1007172.t001
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was genotyped on the Illumina Omni 2.5 million SNP chip, and imputed against the 1000
Genomes reference panel (Phase 3) [10] and a Tanzanian parent-child trio panel (see below),
using Beagle 4.1 [11], leading to 15.2 high quality SNPs. These markers were complemented by
180 SNPs within malaria candidate genes, including HBB (encoding HbS) [3, 4, 5] on the same
cases and controls. DNA from a validation cohort of 78 healthy parent and child trios and 13 inde-
pendent individuals (“Trios dataset”, n = 247) were whole genome sequenced using Illumina
HiSeq2500 technology. For the GWAS samples, a principal component analysis (PCA) using all
genome-wide SNPs revealed a low degree of stratification by ethnicity and case-control status (S1
Fig) and potential cryptic relatedness due to familial clustering. A similar analysis revealed that
GWAS and Trio sample clusters overlap, and there is some separation from the other 1000
Genome African populations, including Yoruba (Nigeria) and Luhya (Kenya) (S1 Fig).
Association analysis
GWAS analysis was undertaken with EMMAX mixed model regression [12], controlling for
age as a fixed effect and relatedness (represented in a kinship matrix) as a random effect to
account for the cryptic population clustering. Separate models of association were fitted for
each SNP (additive, heterozygous, dominant, recessive), with their respective genomic infla-
tion factors all being close to one (see S1 Fig for the heterozygous results), consistent with reli-
able adjustment for stratification. A total of 53 SNPs (in 16 genomic regions) were identified
with a significance level below our threshold (P<1x10
-6) (Fig 1, Table 2, S1 Table). Relaxing
the stringency would lead to 258 SNPs with a p-value below 1x10
-5 and 2,322 below a threshold
of 1x10
-4. As expected, the most significant association was with the sickle cell locus, rs334
(P = 8.59x10
-13, heterozygous odds ratio = 0.07) (Table 2). Controlling for HbS status through
a complementary conditional GWAS demonstrated our top associations as robust against link-
age with rs334 (Table 2, S1 Table).
Novel associations of note also include SNPs within the KLHL3-MYOT region (13 SNPs,
Min P = 5.85x10
-7, Additive OR = 0.590), the IL23R-IL12RB2 region (7 SNPs, Min P = 7.98x10-7,
Recessive OR = 0.479), FAM155A (6 SNPs, Min P = 6.24x10-7, Additive OR = 0.207), and
CSMD1 (5 SNPs, Min P = 7.98x10-7, Additive OR = 4.795). (Fig 2). Three significant SNPs are
also found within both LINC00943/4 and lincRNA AF146191.4–004.
Lone SNP associations are present within proximity of TREML4 (P = 1.21x10-7, Heterozy-
gous OR = 4.087), zinc finger-containing ZNF536 (P = 8.69x10-7, Recessive OR = 0.507),
C4orf17 (P = 3.75x10-7, Recessive OR = 0.289), and near LINC00670 (P = 2.15x10-7, Additive
OR = 3.867). And finally, three intergenic regions display clusters of significance, most notably
a region within chromosome 5 (43,892,232–43,964,366bp; Min P = 2.17x10
-7, Heterozygous
OR = 0.354), as well as regions within chromosome 7 and 11.
As expected, allele frequencies of the putative polymorphisms within the Trios dataset are
generally equivalent to frequencies in our case and control groups, whilst there were some dif-
ferences from the 1000 Genomes populations, including within the HBB locus (Table 2).
Using the Trios dataset, we sought to identify structural variants that could confound the asso-
ciation analysis or be putative hits. We identified no structural variants within HBB, IL-
12RBR2 or LINC00943/4, one deletion (2,904bp) within IL23R, and 152 deletions within
KLHL3 (63 distinct variants, all singletons except for one 1,325bp deletion in 91 individuals)
(S2 Table). None of the common variants are in linkage disequilibrium with the putative
GWAS hits, and eight putative regions had structural variants in the Tanzanian trios, but were
absent in the 1000 Genomes populations (S2 Table).
Subtype specific association analyses were undertaken for those SNPs found to be signifi-
cantly associated with severe malaria in the primary GWAS (Table 2). The majority of
Genome-wide association analysis of severe malaria in Tanzania
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significant associations are with the hyperlactataemia subtype, a phenotype that includes
57.0% of cases, with variants within FAM155A, and the HBB and KLHL3/MYOT regions
exhibiting associations exceeding our 1x10
-6 significance threshold. In contrast, variants within
IL-23R, IL-12RB2, CSMD1, ZNF536 and TREML4 appear to be most significantly associated
with severe malarial anaemia, who comprised 49.2% of cases.
Candidate associations
Candidate SNPs identified in previous studies, with the same individuals, were included to
provide appropriate context for novel findings. ABO blood group, USP38, FREM3 and alpha-
thalassemia have previously been putatively associated with severe malaria in a Tanzanian
Fig 1. Genome-wide association and selection plots. a) Case-Control SNP Associations. Red line indicates genome-
wide significance at 1x10
-6, blue line indicates genome-wide suggestive significant at 1x10
-4; b) Combined population iHS
selection. Red lines indicate significance for absolute iHS scores of 4 or greater; c) Case-Control XP-EHH selection. Red
lines indicate significance for absolute XP-EHH scores of 4 or greater.
https://doi.org/10.1371/journal.pgen.1007172.g001
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population [3, 5], but these associations are no longer statistically significant (P>10−4) at a
more stringent GWAS significance threshold (S3 Table). We also performed targeted imputa-
tion of HLA haplotypes within the MHC, finding the most significant SNP to be rs1264362,
which demonstrated a marginal association with hyperlactatemia (additive model P = 2.33x10
-5).
For the analysis of structural variation within candidate regions in the Trios dataset, we
identified 28 distinct deletions within FREM3, of which all but one are present in only one
individual, and six distinct deletions in GYPB, for which copy number variation has previously
been identified [6]. Nine distinct variants were identified in ABO, including six duplications,
one deletion, one insertion and one inversion. All such ABO variants are present in single indi-
viduals, though 18 individuals have a 23bp insertion. In contrast to a diversity of structural var-
iation present within HLA and the wider MHC region, minor frequency variants were
identified in ATP2B4 (25 deletions across 25 samples), MARVELD3 (five deletions across five
samples), HBA2 (3 deletions across three samples), and HBA1 (one sample with one deletion).
No structural variants were found in HBB or USP38 (S2 Table).
We imputed structural variants within the wider region of human glycophorin genes (gypA,
gypB, gypE) on chromosome four, using 55 distinct large polymorphisms identified in 59 indi-
viduals within our Trios dataset (S2 Table). The glycophorin region is structurally highly
diverse, and specific individual variants are of low frequency (mean frequency: Case Control
dataset = 0.098, Trios dataset = 0.022), consistent with observations in other African popula-
tions [7]. Whilst these large variants could be potentially protective against severe malaria, we
identified no significant associations looking at each individually (P 0.301). Grouping these
variants into forms based on genomic location and function may enhance signals within this
region, but could also introduce experimenter bias. Further, there exists a multitude of poten-
tial variant combinations analysis of which, without specific hypotheses, could risk so-called ‘P
hacking’. A full and in-depth analysis of this region is required but beyond the scope of this
study.
Table 2. More significant SNP associations per feature (P<1x10-6).
SNP Gene n SNPs Location Minimum P Conditional P Subtype P
rs334 HbS (in HBB) 40 11:5248232 HET: 8.59E-13 - HL: 1.81e-09
rs9296359 TREML4 1 6:41205690 HET: 1.21E-07 HET: 4.42e-07 SMA: 3.29e-07
rs149085856 Intergenic (LINC00670) 1 17:12399526 ADD: 2.15E-07 ADD: 1.06e-06 HL: 2.81e-07
rs113449872 Intergenic 20 5:43909343 HET: 2.17E-07 HET: 2.93e-07 SMA: 2.92e-05
rs11335470 LINC00944 3 12:127237620 HET: 2.52E-07 HET: 1.86e-06 HL: 9.04e-05
rs73832816 C4orf17 1 4:100429757 REC: 3.75E-07 REC: 9.48e-07 CM: 1.02e-06
rs17624383 Intergenic 3 7:53676837 ADD: 5.62E-07 ADD: 3.28e-06 RD: 4.61e-07
rs2967790 KLHL3, MYOT 13 5:137011761 ADD: 5.85E-07 ADD: 2.46e-06 HL: 8.65e-06
rs144312179 FAM155A 6 13:108228013 ADD: 6.24E-07 ADD: 2.92e-06 HL: 1.35e-06
rs114169033 AF146191.4–004 (lincRNA) 3 4:190717704 ADD: 6.67E-07 ADD: 1.30e-06 RD: 5.62e-07
rs6682413 IL23R, IL12RB2 7 1:67731614 REC: 7.98E-07 REC: 1.03e-06 SMA: 1.23e-04
rs73505850 CSMD1 5 8:4754838 ADD: 7.98E-07 ADD: 1.42e-06 SMA: 1.20e-05
rs8109875 ZNF536 1 19:31069639 REC: 8.69E-07 REC: 3.57e-06 SMA: 2.80e-05
rs1878468 AC108142.1 (antisense) 1 4:182822332 HET: 8.98E-07 HET: 1.19e-06 HL: 8.10e-07
rs3133394 Intergenic 4 11:130417522 ADD: 9.41E-07 ADD: 1.08e-06 CM: 9.49e-06
Allele models: ADD Additive, HET Heterozygous, DOM Dominant, REC Recessive. Subtype significances: HL Hyperlactatemia; SMA Severe Malarial Anaemia; RD
Respiratory Distress; CM Cerebral Malaria. Locations correspond to the GRCh37 reference genome. Minimum P indicates the most significant P for feature within the
case-control GWAS, whilst Condition and Subtype Ps indicate the most significant P value for those SNPs when controlling for rs334 status, or considering the severe
malarial subtypes.
https://doi.org/10.1371/journal.pgen.1007172.t002
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Evidence of positive selection
Two approaches were applied to identify regions under recent positive selection within the
Tanzanian GWAS population as a whole (Integrated Haplotype Score, iHS) [13], or between
the cases and controls (Cross-Population Extended Haplotype Homozygosity, XP-EHH) [14].
A common genome-wide absolute score threshold of 4 (equivalent to P = 6.3x10
-5) was estab-
lished for both approaches. At this threshold iHS identified 244 loci, 116 (47.5%) within chro-
mosome 6. Ninety-four of these significant signals are within the MHC, with three loci within
HLA-DOA having an absolute score greater than 6. Other MHC genes with significant signals
include the immunophilin FKBP5 (35732-37931bp, 9 SNPs, iHS: 4.00–4.84), SAMD3 (12490-
13053bp, 6 SNPs, iHS: 4.00–4.68) and the exocytosis regulator RIMS1 (72805811-72828559bp,
3 SNPs, iHS: 4.17–4.62) (S4 Table). Most notably, two regions within chromosome 17
(3496105-3689132bp, 6 SNPs, 8 genes including integrin ITGAE) and chromosome 19
(38743962-38900106bp, 14 SNPs, 10 genes including two transmembrane channels) represent
regions with a high density of selection signals, akin to those within the MHC. Further signals
of note include the transcription factor ZFHX3 (ATBF1) (chr. 16, 16326-73133bp, 3 SNPs, iHS:
Fig 2. Region plots for most significant SNP associations. Green regions highlight genes of interest, as indicated by sub-plot headers.
The red line indicates genome-wide significance at 1x10
-6, whilst the blue line indicates genome-wide suggestive significant at 1x10
-4.
https://doi.org/10.1371/journal.pgen.1007172.g002
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4.27–4.91), ABHD5 (chr. 3, 43794949bp, 1 SNP, iHS: 4.75), DUSP19 & NUP35 (chr. 2, 99180–
18528, 3 SNPs, iHS: 4.30–4.66), surface tyrosine-kinase receptor ERBB4 (chr. 2: iHS: 4.31–
4.54), transcription-associated RORC (chr. 1, 151792842-151817543bp, 2 SNPs, iHS: 4.31–
4.66).
No structural variation was identified in ABHD5 or DUSP19, whilst variants were present
but rare for the remaining iHS hits (S2 Table). In total, two deletions were identified in RORC,
three in ZFHX3, NUP35, and ITGAE, one of which is an 86bp deletion found in seven individ-
uals, and 14 deletions and a 31bp insertion in RIMS1. Particularly variable are ERBB4 and
FKBP5 for which we identify 49 and 75 distinct variants respectively. ERBB4 consists of 44
deletions, four insertions, and one inversion, whilst FKBP5 consists of 70 deletions, three
duplications, one insertion, and one inversion.
The between case-control XP-EHH approach identifies 10 significant SNPs across six
genetic regions (S5 Table). Relative selection for the control population lies within three
regions, including POM121L12 (XP-EHH: 4.33), SYNJ2BP, ADAM21,ADAM20 (XP-EHH:
4.12 to 5.57) and ERG (XP-EHH: 4.04), whilst three regions are under relative selection in the
case population, including MCUR1 (XP-EHH: -4.26), GCLC (XP-EHH: -4.69) and the MHC
(XP-EHH: -4.02) (S5 Table). We identify no structural variants within POM121L12,
ADAM21, or ADAM20, but a singleton 75bp deletion in SYNJ2BP, two deletions within
MCUR1, three deletions in GCLC, and 20 distinct deletions within ERG, of which 8 individuals
share a 106bp deletion and 6 share a 325bp deletion (S2 Table).
Discussion
As expected, the most significant SNP association is the heterozygous protective rs334 effect
(P = 2.61x10
-13), with nine further SNPs within HBB also being significantly associated with
resistance to severe disease. SNPs in other candidate genes, including FREM3, GYPA, GYPB
and USP38 [3], did not exceed a significance threshold of 1x10-6, and their p-values were differ-
ent (greater) to those previously published because of the use of the more conservative
EMMAX mixed model regression [12]. Marginal evidence for a role of HLA association with
severe malaria was also identified, and is broadly consistent with previous work in a West Afri-
can population that demonstrated that carriers of HLA Class I Bw53 and HLA class II
DRB11302-DQB10501 were protected against severe malaria [15]. Note that our targeted
imputation of HLA utilised a Caucasian reference panel and may therefore overlook further
true associations within the HLA locus. Further, we identified signals of positive selection
within the MHC region, this being consistent with malaria as a driver of MHC polymorphism
in the human population [16, 17].
Of the novel SNP associations identified here, two of the top candidates are located between
the interleukin receptors IL-23R and IL-12RB2, a region that has been identified in GWAS of
other inflammatory and immune-linked diseases [18]. IL-12 and IL-23 are related pro-inflam-
matory cytokines that share both the p40 subunit and the IL-12Rβ1 receptor subunit. IL-12 sig-
nals through a receptor comprising IL-12Rβ1 and IL-12Rβ2 and is a potent inducer of IFN-γ
which mediates both clearance of infection and immunopathology in infections with Plasmo-
dium parasites. IL-23 signalling (through its receptor, comprising IL-12Rβ1 and IL-23R) pro-
motes transcription of RORC which encodes RORγ, a transcription factor involved in
generation of IL-17. RORC was found to be under recent positive selection in our analysis, fur-
ther supporting the importance of the pathway. Decreased IL-12 levels have been associated
with progression from uncomplicated malaria to severe disease, specifically an increased risk
of severe malarial anaemia in children [19, 20]. Variants in IL-12B have been linked to P. fal-
ciparum parasite density and associated with protection against cerebral malaria in children
Genome-wide association analysis of severe malaria in Tanzania
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whilst, variants in the related IL-12A and IL-12RB1 loci have been associated with protection
against severe malarial anaemia among children in western Kenya [19]. Conversely, the IL-23/
IL-17 immune pathway has been implicated in the development of inflammatory reactions in
children that develop severe malarial anaemia [21], in multi-organ dysfunction and acute
renal failure in adult P. falciparum cases from India [22] and with the risk of cerebral malaria
in Africa [23]. IL-23R haplotypes have also been associated with increased susceptibility to
severe malarial anaemia in Kenya [24].
Three significantly associated SNPs are present within LINC00944, with one being 80bp
from a known CTCF binding site [25]. Structurally, although the LINC00943/4 region is a
known deletion site [25], we identified no such deletions within the region in our ‘Trios’ data-
set. Broader functionality of this long intergenic non-coding RNA is unclear, given limited
experimental characterisation, making it difficult to determine a role for these SNP variants.
A strong association peak was also identified within KLHL3, kelch-like protein 3, being a
region known to contain an enhancer and various deletions [25]. Correspondingly, we identify
152 such deletions within our Trios reference panel, of which 62 distinct variants are present
in only one individual and one 1,325bp deletion is present in 91 individuals. This frequent
deletion is located within an open chromatin-containing region between 137,022,562 and
137,023,887bp. Mutations of KLHL3 have previously been linked with hypertension and meta-
bolic acidosis [26] suggesting that these novel SNP associations and deletions may prime indi-
viduals to have a greater risk for severe malarial acidosis (hyperlactataemia).
A number of the most significantly associated SNPs are present as lone, or paired, associa-
tions rather than “stacks”. This includes SNPs within or very near to TREML4 and ZNF536.
Whilst this may demonstrate false positive outliers, the existence of these SNPs and their
minor frequencies are confirmed in our Trios reference panel.
The broad picture of whole population iHS selection is unsurprising, with the MHC region
demonstrating the most striking evidence for recent selective sweeps. Our results are also con-
sistent with a number of previously identified iHS signals, such as those for loci containing the
alcohol dehydrogenase ADH7, cadherin PCDH15, synaptotagmin SYT1, the nociception
receptor TRPV1, and the transmembrane protein SPINT2 [27]. It should also be emphasised
that our iHS signals reflect selection within our case-control dataset and therefore oversample,
relative to a general Tanzanian population, for those signals associated with susceptibility to
severe malaria.
Recent differential selection between the case and control groups, as determined by
XP-EHH, identified very few significant signals. There is likely to be limited differential selec-
tion between subsets of a closely related population, despite malaria infection being a strong
selector. We identified the MHC, GCLC, MCUR1, POM121L12 and the SYNJ2BP-ADAM21-
ADAM20 region. The strongest of these signals covers ADAM20 and ADAM21, both members
of a larger family of disintegrins and metalloproteinases that are believed to be exclusively
expressed in the testis [28]; this association might simply reflect differences in the gender ratio
between the cases and controls, for which XP-EHH does not control. Selection for this region
is more likely driven by a variant of SYNJ2BP, a Synaptojanin-2 binding protein with potential
roles in membrane trafficking and signalling [29].
Our previous work has demonstrated that novel associations with potentially significant
roles in malaria susceptibility remain to be uncovered [3], and here we show that an integrated
approach that identifies signals of association, selection and structural variation can empower
such studies. However, with only 914 individuals in this study, sample size is a notable limita-
tion for interpretation. Initial approaches to account for this were pursued through robust
contextualisation of novel variants within the secondary ‘Trios’ dataset, and the wider 1000
Genomes project. More generally, it remains vital that further validation, through larger scale
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studies, be undertaken to better characterise the SNP and structural variants uncovered. This
is particularly true for structural variation such as within KLHL3, which may impact gene
expression and would therefore benefit from incorporation of transcriptomic data.
Distributions of human genetic variants with putative roles in P. falciparum malaria suscep-
tibility are diverse. The HbS sickle cell polymorphism is present across most regions of sub-
Saharan Africa but is known to have arisen multiple times leading to a number of distinct hap-
lotypic backgrounds [30]. Similarly, other variants, such as G6PD polymorphism and glyco-
phorin structural variants vary both in frequency across populations and in their direction of
association, leading in some cases to allelic heterogeneity that may be subtype specific. Many
protective variants identified within our study, such as IL-23R and KLHL3, were found at simi-
lar frequencies within the ‘Trios’ dataset but differed from the global 1000 Genomes panel, and
may therefore represent examples of Tanzanian- or regional-specific associations. Such vari-
ants are informative to our understanding of human-parasite interactions, yet risk being over-
looked in inadequately designed studies. Ultimately, human GWAS in parallel with whole
genome sequencing of host and parasites in large study populations across Africa will be cru-
cial to unravelling host genetic and parasite interactions that could lead to novel malaria con-
trol measures such as vaccines.
Methods
Ethics statement
All DNA samples were collected and genotyped following signed and informed written con-
sent from a parent or guardian. Ethics approval for all procedures was obtained from both
LSHTM (#2087) and the Tanzanian National Institute of Medical Research (NIMR/HQ/R.8a/
Vol.IX/392).
Study participants and phenotypes
All participants were from the Tanga region of North-Eastern Tanzania, as described previ-
ously [3]. Briefly, severe malaria cases (n = 449) were recruited in the Teule district hospital
and surrounding villages in Muheza district, Tanga region, Tanzania between June 2006 and
May 2007. The controls (n = 465) were recruited, matched on ward of residence, ethnicity and
age (given in months), during August 2008 from individuals without a recorded history of
severe malaria [3]. Four severe malaria subtypes were identified within case individuals includ-
ing hyperlactatemia (Blood lactate > 5 mmol/L, n = 256), severe malarial anaemia (Hemocue
Hb< 5g/dL, n = 221), respiratory distress (n = 124) and cerebral malaria (Blantyre coma score
<5, n = 120) (Table 1). Parasite infection was initially assessed by rapid diagnostic test (HRP-2
–Parascreen Pan/Pf) and confirmed by double read Geimsa-stained thick blood films.
A further 247 anonymously sampled individuals, consisting of 78 healthy parent and child
trios (156 parents, 78 children, 13 singletons; 80 (32.4%) Chagga, 77 (31.2%) Pare, 90 (36.4%)
Wasambaa), were collected between 2007 and 2008. These individuals are those that had no
current illness or no history of malaria. The samples were collected from highland, medium
and lowland villages near the Kilimanjaro, Pare and West Usambara mountains in the Tanga
region of Tanzania. This is a region that experiences low to medium to high levels of malaria
transmission. This dataset was used to confirm allele frequencies and identify candidate region
structural variation within the general Tanzanian population, as well as to impute variants
onto the case-control set.
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Sample genotyping, sequencing and imputation
DNA was extracted from processed blood samples, as described previously [3, 5]. The DNA
was genotyped on the Illumina Omni 2.5 million SNP chip and SNP genotypes called by the
MalariaGEN Resource Centre at the Sanger Institute and the Wellcome Trust Centre for
Human Genetics, using previously described methods [6,7]. These data were complemented
by Iplex genotyping assays that included 180 single nucleotide polymorphisms (SNP) across
50 loci on the same individuals [3]. 107 additional candidate SNPs, including the HbS SNP
rs334, were included from previous candidate genotyping of the same case-control individuals;
their collection having been described previously [3]. DNA for the individuals in the Trio data-
set (n = 247) was sequenced using Illumina HiSeq2500 technology at the Sanger Institute, and
aligned to the GRCh37 build of the human genome [7]. The minimum genome-wide coverage
across the samples was 22-fold. SNPs were called from the alignments using the standard sam-
tools-bcftools pipeline [31]. This process led to 2,788,671 high quality SNPs with quality scores
of at least 30 (1 error per 1000bp) and perfect trio-consistent genotype calls. Haplotypes were
phased from genotypes using SHAPEIT (www.shapeit.fr; default settings). Structural variants,
including duplications, deletions, insertions and inversions, were identified within the second-
ary ‘Trios’ dataset for candidate regions using DELLY version v0.7.3 [32]. This software was
applied using default settings, and its use in pipelines has been shown to reliably uncover struc-
tural variants from the 1000 Genomes Project, and validation experiments of randomly
selected deletion loci show a high specificity [32]. Structural variants greater than 100,000
basepairs in length were removed to conservatively exclude false positives.
To increase genome-wide SNP resolution, our initial case-control dataset was imputed
using a combined reference panel of the Phase 3 1000 Genomes project [10] and children
within the trio dataset, using Beagle 4.1 [11]. This allowed for the inclusion of 13.5 million
additional high quality SNPs, to a total of 15.2 million SNPs. A total of 621,019 SNPs were
removed from the pre-imputation dataset due to evidence of: (i) deviations in genotypic fre-
quencies from Hardy-Weinberg equilibrium (HWE) as assessed using a chi-square test
(>0.0001); (ii) high genotype call missingness (>10%); or (iii) low minor allele frequency
(<0.01). 51 individuals were removed due to: (i) genotypic missingness (>0.1); (ii) abnormal
PCA clustering or (iii) missing malaria phenotype data. 849,134 strand flips were identified
with snpflip, with these being corrected pre-imputation with Plink v1.07. Raw hybridisation
plots were manually verified for all top non-imputed GWAS associations, excluding rs334 for
which the data was unavailable. Linkage disequilibrium between SNPs in close genomic dis-
tance was calculated using Plink v1.07 [33].
Targeted imputation was performed for HLA haplotypes within the major histocompatibil-
ity complex using 9,785 high quality SNPs within the region; for this we utilised SNP2HLA
software (version 1.0.3) and the default Caucasian reference panel [34]. Association tests for
this targeted analysis were performed through the pipeline described above. Similarly, 1,202
structural variants (698 deletions, 311 duplications, 19 insertions, 174 inversions) within chro-
mosome four were imputed into our primary ‘case-control’ dataset using IMPUTE2 with
default parameters, akin to standard SNP imputation. This approach allowed us to perform
association analysis on those structural variants using EMMAX mixed model regression [12].
Trio parental SNP data was also used to provide additional context for our case-control SNPs
within the wider Tanzanian population, as seen in S1 Table.
Association analysis
Case-Control association analysis of SNPs was undertaken with EMMAX mixed model regres-
sion [12], controlling for age as a fixed effect and relatedness (represented by a kinship matrix)
Genome-wide association analysis of severe malaria in Tanzania
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007172 January 30, 2018 11 / 15
as a random effect (to reduce associations relating to familial clustering). Several genotypic
models were implemented separately, including additive, heterozygous, dominant and reces-
sive. Minimum P values from each model were utilised for top hit identification. Odds ratios
were estimated with Plink v1.07 [33]. Our complementary conditional GWAS shared the pipe-
line for the main GWAS, but with HbS status added as an additional covariate. To evaluate the
statistical potential of our GWAS study, we performed a retrospective power calculation
(using http://zzz.bwh.harvard.edu/gpc/cc2.html). A study of 460 cases and 460 controls can
detect odds ratios of at least 2 for a high risk allele minor allele frequency of 5% with a statisti-
cal power of 85% (and type I error of 10−6). A significance threshold of 10−6 was established
using a permutation approach [35]. In particular, both the case-control status of the chromo-
somes were randomly permuted 10,000 times. From each of the 10,000 random experiments,
we determined the maximum chi-square statistics (across the four genotypic tests) over all
SNPs genotyped. We ordered these statistics and then calculated the 95 percentile. This was
the estimate of the 0.05 significance level for the experiment performed, assuming inference is
taken with respect to maximum chi-square statistic observed over all genotyped SNPs, and
accounts for the linkage disequilibrium between SNPs and correlation between the results
from applying the 4 genotypic tests.
Selection analysis
Whole population Integrated Haplotype Scores (iHS) [13] and case-control Cross-Population
Extended Haplotype Homozygosity (XP-EHH) [14] were calculated and normalised over the
whole genome using selscan and norm [36]. Core SNPs with a minor allele frequency below
0.01 were excluded from this analysis. In this context, high iHS values indicate a whole popula-
tion selection signal whilst positive XP-EHH values indicate relative selection within the con-
trol population and negative XP-EHH values indicate relative selection within the case
population. We looked for structural variants in regions with SNP-based signals of positive
selection, as it possible that selection may actually be driven by structural variants (see [37] for
an example).
Supporting information
S1 Fig. Population structure. Visualisation of the first two principal components, by (a) case-
control status and (b) father’s ethnicity, highlights the existence of cryptic relatedness; (c) Prin-
cipal component analysis reveals that the ‘Trios’ and primary ‘Case-Control’ participants over-
lap and are within the African cluster of the 1000 Genomes dataset; (d) Quantile-quantile plot
for the observed and expected P values of the heterozygous model genome-wide association
statistic.
(PNG)
S1 Table. Full list of significant SNP associations, including odds ratios and minor allele
frequencies.
(DOCX)
S2 Table. Structural variation identified within regions consisting of GWAS associations,
known malaria candidates and sites under selection (iHS, XP-EHH).
(DOCX)
S3 Table. Candidate SNP associations.
(DOCX)
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S4 Table. Regions under potential whole population positive selection (absolute iHS > 4).
(DOCX)
S5 Table. Regions under potential differential selection between cases and controls (abso-
lute XP-EHH > 4).
(DOCX)
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